Matthew Simms

2.9k total citations
41 papers, 1.2k citations indexed

About

Matthew Simms is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Matthew Simms has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 14 papers in Surgery. Recurrent topics in Matthew Simms's work include Prostate Cancer Treatment and Research (15 papers), Cancer Cells and Metastasis (6 papers) and Immunotherapy and Immune Responses (6 papers). Matthew Simms is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Cancer Cells and Metastasis (6 papers) and Immunotherapy and Immune Responses (6 papers). Matthew Simms collaborates with scholars based in United Kingdom, United States and Finland. Matthew Simms's co-authors include Norman J. Maitland, Fiona M. Frame, Anne T. Collins, Vincent M. Mann, V. M. Mann, T R Terry, Michael J. Stower, Deborah O’Connell, Adam M. Hirst and Davide Pellacani and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Matthew Simms

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Simms United Kingdom 17 409 346 271 227 184 41 1.2k
Charles Hudd United Kingdom 8 262 0.6× 236 0.7× 191 0.7× 63 0.3× 98 0.5× 20 815
Chunxiang Li China 18 524 1.3× 261 0.8× 327 1.2× 68 0.3× 232 1.3× 83 1.3k
Helen Valentine United Kingdom 21 792 1.9× 268 0.8× 281 1.0× 173 0.8× 730 4.0× 48 1.5k
Sang‐Yeob Kim South Korea 24 797 1.9× 240 0.7× 440 1.6× 79 0.3× 262 1.4× 81 1.6k
Han Hao China 16 446 1.1× 183 0.5× 288 1.1× 79 0.3× 127 0.7× 46 1.6k
Peter M. Kanter United States 21 620 1.5× 195 0.6× 417 1.5× 78 0.3× 164 0.9× 48 1.4k
Paolo Visca Italy 25 954 2.3× 242 0.7× 419 1.5× 94 0.4× 777 4.2× 74 1.8k
Raj Kumar United States 19 577 1.4× 144 0.4× 322 1.2× 161 0.7× 175 1.0× 54 1.4k
T. Förster Switzerland 16 458 1.1× 460 1.3× 137 0.5× 43 0.2× 60 0.3× 37 1.2k
Hirohisa Ogawa Japan 24 556 1.4× 399 1.2× 352 1.3× 58 0.3× 281 1.5× 89 1.6k

Countries citing papers authored by Matthew Simms

Since Specialization
Citations

This map shows the geographic impact of Matthew Simms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Simms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Simms more than expected).

Fields of papers citing papers by Matthew Simms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Simms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Simms. The network helps show where Matthew Simms may publish in the future.

Co-authorship network of co-authors of Matthew Simms

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Simms. A scholar is included among the top collaborators of Matthew Simms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Simms. Matthew Simms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rodrigues, Greta, et al.. (2019). A Rare Case of Skene’s Gland Adenocarcinoma. Clinical Genitourinary Cancer. 18(3). e300–e302. 11 indexed citations
3.
Pellacani, Davide, Alastair Droop, Fiona M. Frame, et al.. (2018). Phenotype-independent DNA methylation changes in prostate cancer. British Journal of Cancer. 119(9). 1133–1143. 11 indexed citations
4.
Taurozzi, Alberto J., Michelle Wantoch, Marie‐Christine Labarthe, et al.. (2017). Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program. PLoS ONE. 12(11). e0188228–e0188228. 17 indexed citations
5.
Hirst, Adam M., Matthew Simms, V. M. Mann, et al.. (2015). Low-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cells. British Journal of Cancer. 112(9). 1536–1545. 148 indexed citations
6.
Pellacani, Davide, Alastair Droop, Fiona M. Frame, et al.. (2014). DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation. Cell Death and Differentiation. 21(5). 761–773. 27 indexed citations
7.
Rane, Jayant K., Alastair Droop, Davide Pellacani, et al.. (2014). Conserved Two-Step Regulatory Mechanism of Human Epithelial Differentiation. Stem Cell Reports. 2(2). 180–188. 16 indexed citations
8.
Kroon, Paula, Paul A. Berry, Michael J. Stower, et al.. (2013). JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells. Cancer Research. 73(16). 5288–5298. 145 indexed citations
9.
Ulukaya, Engı̇n, Fiona M. Frame, Buse Cevatemre, et al.. (2013). Differential Cytotoxic Activity of a Novel Palladium-Based Compound on Prostate Cell Lines, Primary Prostate Epithelial Cells and Prostate Stem Cells. PLoS ONE. 8(5). e64278–e64278. 39 indexed citations
10.
Gill, Jonathan, J. Cast, Philip Thomas, & Matthew Simms. (2013). Orthotopic neobladder perforation: an unusual presentation of small bowel obstruction. Journal of Surgical Case Reports. 2013(7). rjt045–rjt045. 1 indexed citations
11.
Polson, Euan S., John L. Lewis, Vincent M. Mann, et al.. (2013). Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells. Nature Communications. 4(1). 1623–1623. 37 indexed citations
12.
Frame, Fiona M., Davide Pellacani, Anne T. Collins, et al.. (2013). HDAC inhibitor confers radiosensitivity to prostate stem-like cells. British Journal of Cancer. 109(12). 3023–3033. 50 indexed citations
13.
Simms, Matthew, et al.. (2004). The management of lymph node metastasis from bladder cancer. European Journal of Surgical Oncology. 31(4). 348–356. 11 indexed citations
14.
Simms, Matthew, S. S. Huq, & J.K. Mellon. (2003). Testicular prostheses: a new technique for insertion. British Journal of Urology. 93(1). 179–179. 7 indexed citations
15.
Parkinson, Richard, et al.. (2003). A Vaccination Strategy for the Long-Term Suppression of Androgens in Advanced Prostate Cancer. European Urology. 45(2). 171–175. 17 indexed citations
16.
Scholfield, David, Matthew Simms, & M.C. Bishop. (2003). MUC1 mucin in urological malignancy. British Journal of Urology. 91(6). 560–566. 13 indexed citations
17.
Simms, Matthew, Roberto Chiarle, Fabienne Mackay, et al.. (2001). Induction of germinal centers by MMTV encoded superantigen on B cells.. Developmental & Comparative Immunology. 8. 201–211. 1 indexed citations
18.
Simms, Matthew, Andrea Murray, David Scholfield, et al.. (2001). Production and characterisation of a C595 antibody- 99m Tc conjugate for immunoscintigraphy of bladder cancer. Urological Research. 29(1). 13–19. 15 indexed citations
19.
Simms, Matthew, Roberto Chiarle, Fabienne Mackay, et al.. (2001). Induction of Germinal Centers by MMTV EncodedSuperantigen on B Cells. Journal of Immunology Research. 8(3-4). 201–211. 6 indexed citations
20.
Simms, Matthew, Alan C. Perkins, M.R. Price, David Scholfield, & M.C. Bishop. (2001). 99m Technetium‐C595 radioimmunoscintigraphy: a potential staging tool for bladder cancer. British Journal of Urology. 88(7). 686–691. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026